These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 1398999)
41. Some galE mutants of Salmonella choleraesuis retain virulence. Nnalue NA; Stocker BA Infect Immun; 1986 Dec; 54(3):635-40. PubMed ID: 3781619 [TBL] [Abstract][Full Text] [Related]
42. Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection. Zhao X; Dai Q; Zhu D; Liu M; Chen S; Sun K; Yang Q; Wu Y; Kong Q; Jia R Sci Rep; 2017 Jul; 7(1):7127. PubMed ID: 28754982 [TBL] [Abstract][Full Text] [Related]
43. Construction and evaluation of a delta cya delta crp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Roland K; Curtiss R; Sizemore D Avian Dis; 1999; 43(3):429-41. PubMed ID: 10494411 [TBL] [Abstract][Full Text] [Related]
44. Salmonella choleraesuis strains deficient in O antigen remain fully virulent for mice by parenteral inoculation but are avirulent by oral administration. Nnalue NA; Lindberg AA Infect Immun; 1990 Aug; 58(8):2493-501. PubMed ID: 1695204 [TBL] [Abstract][Full Text] [Related]
45. [Protective role of Salmonella R mutants in Salmonella infection in mice (author's transl)]. Schlecht S; Westphal O Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):71-88. PubMed ID: 44625 [TBL] [Abstract][Full Text] [Related]
46. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Tacket CO; Kelly SM; Schödel F; Losonsky G; Nataro JP; Edelman R; Levine MM; Curtiss R Infect Immun; 1997 Aug; 65(8):3381-5. PubMed ID: 9234801 [TBL] [Abstract][Full Text] [Related]
47. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes. Matsui H; Fukiya S; Kodama-Akaboshi C; Eguchi M; Yamamoto T J Med Microbiol; 2015 Mar; 64(Pt 3):295-302. PubMed ID: 25589672 [TBL] [Abstract][Full Text] [Related]
48. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium. Matsui H; Suzuki M; Isshiki Y; Kodama C; Eguchi M; Kikuchi Y; Motokawa K; Takaya A; Tomoyasu T; Yamamoto T Infect Immun; 2003 Jan; 71(1):30-9. PubMed ID: 12496146 [TBL] [Abstract][Full Text] [Related]
49. Virulence of Salmonella typhimurium mutants for White Leghorn chicks. Porter SB; Tinge SA; Curtiss R Avian Dis; 1993; 37(2):265-73. PubMed ID: 8363492 [TBL] [Abstract][Full Text] [Related]
50. Salmonella enterica serovar Choleraesuis derivatives harbouring deletions in rpoS and phoP regulatory genes are attenuated in pigs, and survive and multiply in porcine intestinal macrophages and fibroblasts, respectively. Domínguez-Bernal G; Tierrez A; Bartolomé A; Martínez-Pulgarín S; Salguero FJ; Orden JA; de la Fuente R Vet Microbiol; 2008 Aug; 130(3-4):298-311. PubMed ID: 18313237 [TBL] [Abstract][Full Text] [Related]
51. Construction of an aroA mutant of Salmonella serotype Gallinarum: its effectiveness in immunization against experimental fowl typhoid. Griffin HG; Barrow PA Vaccine; 1993; 11(4):457-62. PubMed ID: 8470431 [TBL] [Abstract][Full Text] [Related]
52. [Preparation of stable Salmonella vaccine strains through combination of 2 independently attenuating markers with no limitation on growth]. Linde K Arch Exp Veterinarmed; 1980; 34(1):19-32. PubMed ID: 6998400 [TBL] [Abstract][Full Text] [Related]
53. A comparison of virulent and avirulent strains of Salmonella choleraesuis and their ability to invade Vero cell monolayers. Roof MB; Kramer TT; Roth JA Vet Microbiol; 1992 Mar; 30(4):355-68. PubMed ID: 1585627 [TBL] [Abstract][Full Text] [Related]
54. Construction of delta aroA his delta pur strains of Salmonella typhi. Edwards MF; Stocker BA J Bacteriol; 1988 Sep; 170(9):3991-5. PubMed ID: 2842296 [TBL] [Abstract][Full Text] [Related]
55. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain. Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248 [TBL] [Abstract][Full Text] [Related]
56. Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect. Eisenstein TK; Meissler JJ; Miller SI; Stocker BA Vaccine; 1998 Jan; 16(1):24-32. PubMed ID: 9607005 [TBL] [Abstract][Full Text] [Related]
57. Immunogenicity and protective efficacy of a Salmonella Enteritidis sptP mutant as a live attenuated vaccine candidate. Lin Z; Tang P; Jiao Y; Kang X; Li Q; Xu X; Sun J; Pan Z; Jiao X BMC Vet Res; 2017 Jun; 13(1):194. PubMed ID: 28646853 [TBL] [Abstract][Full Text] [Related]
58. Safety and efficacy of an avirulent live Salmonella choleraesuis vaccine for protection of calves against S dublin infection. Fox BC; Roof MB; Carter DP; Kesl LD; Roth JA Am J Vet Res; 1997 Mar; 58(3):265-71. PubMed ID: 9055972 [TBL] [Abstract][Full Text] [Related]
59. Deletions in Fuche FJ; Jones JA; Ramachandran G; Higginson EE; Simon R; Tennant SM Hum Vaccin Immunother; 2019; 15(6):1427-1435. PubMed ID: 29927725 [TBL] [Abstract][Full Text] [Related]
60. Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon. Coynault C; Robbe-Saule V; Norel F Mol Microbiol; 1996 Oct; 22(1):149-60. PubMed ID: 8899717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]